Brazil’s Over-the-Counter Market

Today’s Latin American Over-the-Counter (OTC) market is riding tailwinds of social ascension and positive regulatory change, enabling healthy category growth despite choppy economic conditions.

OTCs in Latin America have long competed against prescription drugs that were commonly sold “under the counter” without the necessary prescription. It is a common tale that if a consumer felt a sore throat coming on, they could stop by their local pharmacy to pick up antibiotics without a confirmed diagnosis, leading to mounting concerns in the region over bacterial resistance.

However, this began to change in 2010 when both Brazil’s National Health Surveillance Agency (ANVISA) and Mexico’s Ministry of Health stepped up enforcement by requiring prescription duplicates and imposing hefty fines on noncompliant pharmacies.

Download the complete report for more information.

Mariana Romero
Mariana is a Senior Account Manager for Global Health Intelligence and has been a key component of the company since day one. As part of her functions, Mariana assesses clients’ market intelligence solutions and methodologies that will drive ROI decisions. Mariana also oversees primary and secondary research efforts, with a principal focus on capital equipment, medical devices, procedure and epidemiological trends, market activity, hospital data and competitive analysis across emerging markets. Additionally, Mariana leads GHI’s marketing, communication and PR activities.
Recommended Posts

Leave a Comment

Want to stay informed on major healthcare news in Latin America?

Subscribe to GHI Newsletter

Contact Us

Please feel free to contact us at any time. Send us an email and we'll get back to you, asap.

Not readable? Change text.